Meet the Roche Molecular Targeted Therapy team

In Molecular Targeted Therapy, our goal is to target specific genetic changes in tumours that drive survival and proliferation. Upfront we know which patients should benefit from our therapies and which should not. That way, we are only treating patients that are likely to respond. Daily, and almost hourly, there are new innovations that technologically and in the knowledge of disease that give us confidence that not only are we delivering benefits for patients today, but we will continue in the future.

Leave a Reply

(*) Required, Your email will not be published